Top Oklahoma City, OK Biotech Companies (11)

PD-Rx Pharmaceuticals has supplied the healthcare industry with quality products and personal customer service.

Heparinex is a biotechnology company.

Drik provides toxicology services that help pharmaceutical companies identify toxicology requirements in developing new drugs.

Tribal Diagnostics is a CAP-accredited, Native American-owned clinical laboratory that provides high-quality, affordable diagnostic testing for diseases such as diabetes, heart disease, and infectious diseases, with a focus on serving underserved communities and Native American populations.

Biolytx Pharmaceuticals developing a drug focused on promoting wound healing and killing antibiotic resistant bacteria.

Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...

Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in clinical and commercial manufacturing production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking, and support services from its Oklahoma City state-of-the-art facilities.

Tetherex Pharmaceuticals operates in the healthcare industry focusing on biotechnology business.

A personalized medicine company and clinical laboratory focused on autoimmune neuropsychiatric disorders in children and adults.

Linear Health Sciences develops cutting-edge technology to prevent unwanted disconnection of medical tubing from patients.

Amerita, Inc. is a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost-effective delivery settings, a growing bio-pharmaceutical pipeline of